The Software-as-a-Service (SaaS) application offers flexible toolset that allows sponsor and clinical research organization staff to quickly and easily build and manage their own studies. iMedNet EDC includes
The histone reagents are expected to work as tool for researchers seeking to prosecute key drug targets in the field of epigenetics. The modified histone reagent provision will
The evaluation of the safety of JX594 followed by sorafenib in patients with advanced HCC was the primary objective of the study while secondary endpoints included the effect
Under the agreement, EMD Millipore will provide its STEMCCA reprogramming kits for use of iPS cells in research applications. iPS cells, which are discovered by Shinya Yamanaka of
The primary outcome measure, change from baseline on the inattention subscale of the Conners’ Adult ADHD Rating Scale-Investigator-Rated (CAARS-INV), after four weeks of treatment versus placebo was not
The additional indication is for the active immunisation against pneumonia caused by Streptococcus pneumoniae in infants and children from six weeks up to five years of age. The
Lifeline CEO Jim Holmes said the System patent completes Lifeline’s three software patents. ”We now have our Methods, Device and System patents which provide the Company with protection
The FDA said it has received more than 40 reports of burns to the skin in the years since the products have been marketed. OTC topical pain relievers
Sunshine Biopharma president and CEO Steve Slilaty said, "We have made significant recent strides in terms of research results showing the effectiveness of our lead compound against cancer
The project was based on using ERC technology licensed from Yale University to treat type 1diabetes. Shumakov Center Biomedical Research and Technology Institute head and professor Viktor Sevastianov
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.